CURA news

Curaleaf released an investor statement refusing to step aside in its mining bid for Aurora, challenging the Alberta Securities Commission's recent ruling as irrelevant. The statement argues that the ASC's decision does not change the fundamental market value of Curaleaf's enhanced offer.

Curaleaf Holdings challenged Aurora Cannabis's decision to reject Curaleaf's enhanced bid, arguing it undervalues the company and citing selective silence on other potential deal partners.

Curaleaf has filed a Notice of Variation to increase its AM bid for Aurora Cannabis, now valued at US$6.00 per share based on current share prices. This move increases the proposed deal's premium while excluding balance sheet cash, though the expanded generosity is met with Aurora's refusal to engag…

Curaleaf Holdings announced it has extended its offer to acquire Aurora Cannabis and increased the cash consideration per share to US$1.00. The offer is now valid until December 4, 2026.

Curaleaf Holdings announced it will report Q3 2026 financial results after market close on November 3, 2026. The release follows its standard quarterly earnings call schedule.

Curaleaf Holdings was added to the FTSE Canada All Cap Index effective September 18, 2026, increasing liquidity and exposure to Canadian benchmark funds.

Curaleaf Holdings urged Aurora shareholders to accept its offer for a 45% premium. The company also announced a live shareholder Q&A.

Curaleaf filed an application with the Alberta Securities Commission to temporarily halt Aurora Cannabis's at-the-market share issuing program to stop dilution and protect shareholder value during Curaleaf's pending acquisition offer.

Curaleaf Holdings issued a fact sheet refuting statements made by competitor Aurora Cannabis regarding Curaleaf's acquisition proposal. The filing highlights that the offer includes a 45% premium and emphasizes Aurora's financial underperformance and strategic challenges.

Curaleaf reiterated its bid for Aurora Cannabis, emphasizing a 45% premium and future growth potential, while criticizing Aurora’s execution, debt strategy, and declining guidance. The offer has not yet been accepted.

Curaleaf Holdings announced a $4.00 per share offer for Aurora Cannabis, representing a 45% premium to pre-close prices. This follows multiple failed private acquisition attempts.

Curaleaf Holdings reported solid Q2 2026 financial results, achieving a record 50% gross profit margin and net income of $12.5 million, while continuing to demonstrate operational momentum.